• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
IMCS

IMCS

Integrated Micro-Chromatography Systems, Inc (IMCS) is a biotechnology company focused on delivering tools and services to...

  • ABOUT
    • ABOUT IMCS
    • QUALITY POLICY
    • RESEARCH AT IMCS
    • CAREERS
  • PRODUCTS
    • IMCSzyme®
      • IMCSzyme E1F
      • IMCSzyme RT
      • IMCSzyme® CATALOG
    • IMCStips®
      • APPLICATIONS
        • AFFINITY
        • SIZE EXCLUSION
        • NUCLEIC ACIDS
        • ION EXCHANGE
        • REVERSE PHASE
        • PHOSPHOPEPTIDE
      • IMCStips® CATALOG
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • SULFATASES
      • Sulfazyme™ PaS
      • Sulfazyme™ DS
      • Sulfazyme™ β-AS
    • GLYCO REAGENTS
      • GLYCOLIPIDS
      • ACTIVATED SUGARS
      • BIOSYNTHETIC ENZYMES
      • SMALL MOLECULES
    • OTHER PROTEINS
      • PURIFIED STREPTAVIDIN
      • B. pi. β-glucuronidase variant
  • SERVICES
    • BETA-GLUCURONIDASES & SULFATASES
      • β-GLUCURONIDASE VALIDATION SERVICES
      • HIGH-THROUGHPUT TOXICOLOGY WORKFLOWS
    • IMCStips®
      • SAMPLE PREPARATION AUTOMATION
      • HIGH-THROUGHPUT METHOD DEVELOPMENT
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • OTHER SERVICES
      • GLYCAN PRODUCTION (Coming Soon)
      • R&D COLLABORATIONS
      • EXTRACELLULAR VESICLES
  • RESOURCES
    • FAQ
    • IMCSZYME RESOURCES
    • IMCSTIPS RESOURCES
    • SAFETY DATA SHEETS
    • CERTIFICATE OF ANALYSIS
  • LATEST NEWS
    • LATEST NEWS
    • PODCAST
    • BLOG
    • EVENTS
    • WEBINARS
  • CONTACT
  • en
    • en
    • es
    • fr
    • de
    • zh-CN
Image of blue rendered molecular structure

Financial Conflicts of Interest (FCOI) Policy

PURPOSE

This Financial Conflict of Interest Policy (this “Policy”) describes certain legal obligations applicable to Investigators’ disclosure of potential Financial Conflicts of Interest (“FCOI”). The purpose of this Policy is to comply with applicable law and to ensure the objectivity of the research conducted by Integrated micro-chromatography systems, Inc., (“IMCS”), and their respective employees, contractors, and consultants.
Investigators applying for and working on Public Health Services (“PHS”), National Institutes of Health (“NIH”), or National Science Foundation (“NSF”) funded research must disclose significant financial interests that are related to the Investigator’s institutional responsibilities. Investigators are all persons, regardless of title or position, who are responsible for the design, conduct, or reporting of research proposed for funding by the PHS, NIH, or NSF (the foregoing agencies, together with any other organizations providing funding through grant or contract to which the regulations contemplated herein apply, collectively, the “Funding Agencies”), including collaborators or consultants. This Policy provides the framework to identify, evaluate and correct or remove real, apparent and potential conflicts of interest.
This Policy requires that each Investigator, subrecipient, subgrantee and collaborator affiliated with IMCS on a Funding Agency project be in compliance with 42 CFR Part 50, Subpart F for grants and cooperative agreements (and 45 CFR Part 94 for contracts). In addition, these regulations describe NIH’s commitment to preserving the public’s trust that the research supported by the NIH is conducted without bias and with the highest scientific and ethical standards. IMCS intends to comply with these regulations for all other Federal agency grant and contract efforts, as tailored or amended accordingly.

ABBREVIATIONS AND DEFINITIONS

The following abbreviations and definitions are used in this Policy:
CFR Code of Federal Regulations
FCOI Financial Conflict of Interest
NIH National Institutes of Health
NSF National Science Foundation
PHS Public Health Services
SBIR Small Business Innovation Research
SFI Significant Financial Interest
STTR Small Business Technology Transfer
USC United States Code

A “Financial Conflict of Interest” or “FCOI” exists when IMCS reasonably determines that a significant financial interest could directly and significantly affect the design, conduct or reporting of Funded Research.

“Funded Research” means any research funded by a Funding Agency but excludes applications for Phase I support under the SBIR and STTR programs.

“Investigator” means any person (including subrecipients, subgrantees, and collaborators) who is responsible for the design, conduct, or reporting of Funded Research.

“Management” of an FCOI means taking action to address an FCOI, which can include reducing or eliminating the FCOI, to ensure, to the extent possible, that the design, conduct, and reporting of Funded Research will be free from bias.

“Policy Coordinator” means the IMCS FCOI Policy Coordinator.

“Significant Financial Interest” or “SFI” means a financial interest of the Investigator consisting of one or more of the interests described below (including those of the Investigator’s spouse and dependent children) that reasonably appears to be related to the Investigator’s institutional responsibilities.

An “SFI Disclosure” is a report that each Investigator shall submit to the Policy Coordinator: (a) at the time of application for Funded Research and prior to the expenditure of any Funding Agency funds therefor; (b) annually thereafter; (b) in the event of certain sponsored travel, as set forth below; and (c) within thirty (30) days of the discovery or acquisition by an Investigator of any SFI.

SIGNIFICANT FINANCIAL INTERESTS (SFIs)

What is an SFI?

With regard to any publicly traded entity, an SFI exists if the value of any remuneration received by the Investigator (or the Investigator’s spouse or dependent children) from the entity in the twelve months preceding the disclosure and the value of any equity interest in the entity as of the date of disclosure, when aggregated, exceeds $5,000.

With regard to any privately held company, a SFI exists if the value of any remuneration received by the Investigator (or the Investigator’s spouse or dependent children) from the entity in the twelve months preceding the disclosure, when aggregated, exceeds $5,000, or when the Investigator (or the Investigator’s spouse or dependent children) holds any equity interest in the entity (e.g. stock, stock options, or other ownership interest).

For purposes of the definition of an SFI, remuneration includes salary and any payment for services not otherwise identified as salary (e.g. consulting fees, honoraria, paid authorship); and equity interest includes stock, stock options, or other ownership interest, as valued through reference to the public trading price or other reasonable measures of fair market value.

An SFI exists with respect to intellectual property rights and interests (e.g. patents, trademarks, copyrights) upon receipt of (or right to receive) any income or other value related to such intellectual property rights and interests.

With respect to a Significant Financial Interest, Investigators also must disclose (and such disclosure shall constitute an SFI Disclosure) any reimbursed or sponsored travel (i.e., travel which is paid on behalf of the Investigator and not reimbursed to the Investigator so that the exact monetary value may not be readily available) related to their institutional responsibilities; provided, however, that this disclosure requirement does not apply to travel that is reimbursed or sponsored by a federal, state, or local government agency, an institution of higher education as defined at 20 USC 1001(a), an academic teaching hospital, a medical center, or a research institute that is affiliated with an institution of higher education. This disclosure will include, at a minimum, the purpose of the trip, the identity of the sponsor/organizer, the destination, and the duration. Upon receipt of this disclosure, the Policy Coordinator will determine if further information is needed, including a determination or disclosure of monetary value to determine whether the travel constitutes a FCOI.

What is not an SFI?

An SFI does not include the following types of financial interests:

  • salaries, royalties, or other remuneration paid by IMCS to the Investigator if the Investigator is currently employed or otherwise appointed by IMCS, including with respect to intellectual property rights assigned to IMCS and agreements to share in royalties related to such rights;
  • any ownership interest in IMCS held by the Investigator;
  • income from investment vehicles, such as mutual funds and retirements accounts, as long as the Investigator does not directly control the investment decisions made by these vehicles;
  • income from seminars, lectures, or teaching engagements sponsored by a federal, state, or local government agency, an institution of higher education as defined at 20 USC 1001(a), an academic teaching hospital, a medical center, or a research institute that is affiliated with an institution of higher education; or
  • income from service on advisory committees or review panels for a federal, state, or local government agency, an institution of higher education as defined at 20 USC 001(a), an academic teaching hospital, a medical center, or a research institute that is affiliated with an institution of higher education.

SFI DISCLOSURES AND REPORTING PROCESS

Each Investigator shall submit SFI Disclosures (using the IMCS SFI Disclosure Form appended to this Policy) to the Policy Coordinator as follows:

  • at the time of hire or engagement of such Investigator with respect to any Funded Research on which such Investigator shall be working;
  • at the time of application for Funded Research on which such Investigator shall be working and prior to the expenditure of any Funding Agency funds therefore;
  • annually on or before the anniversary date of such Investigator’s initial SFI Disclosure;
  • promptly in the event of certain sponsored travel, as set forth above; and
  • within thirty (30) days of the discovery or acquisition of any SFI by such Investigator.

The Policy Coordinator will review each SFI Disclosure and evaluate whether any such SFI Disclosure has given rise to an FCOI. If it is determined that there is no FCOI, the SFI Disclosure will be filed with the Policy Coordinator’s SFI Disclosure records. If a FCOI is identified, it will be included in IMCS’s FCOI report submitted via the online eRA Commons FCOI module (or, where IMCS is a subgrantee or subawardee, then IMCS will report the FCOI as required under the applicable subgrant or subaward agreement) prior to the expenditure of any Funding Agency funds therefor. IMCS will then report any newly identified FCOIs to the applicable Funding Agency within 60 days of IMCS’s determination thereof. If an Investigator with an FCOI conducts any Funded Research, IMCS shall disclose the FCOI in each public presentation related to the results of the Funded Research.

TRAINING

All Investigators are required to complete training related to this Policy and applicable law as follows:

  • Upon joining IMCS;
  • Prior to engaging in Funded Research;
  • At least once every four years;
  • In the event of any modifications to this Policy that affects an Investigator’s obligations hereunder; and
  • In the event IMCS determines that an Investigator is not in compliance with this Policy or any FCOI management plan. NIH web-based training can be accessed through the NIH website at https://grants.nih.gov/grants/policy/coi/tutorial2018/story_html5.html. Participants are required to provide IMCS with proof of completion.

PUBLIC DISCLOSURE AND RECORDS MANAGEMENT

This policy will be publicly available on IMCS’s website at www.imcstips.com/fcoi-financial-conflict-of-interest, and certain information regarding FCOIs will be available within five days of a qualified written request therefor. IMCS will maintain records of all SFI disclosures, and records of resulting IMCS management or other action with respect to the respective FCOI, for at least three years from the date of submission of the final expenditures report for the applicable Funded Research.

COMPLIANCE AND PENALTIES FOR NON-PERFORMANCE

Within 120 days of any determination by IMCS that an Investigator has failed to comply with this Policy, IMCS shall complete a retrospective review of such Investigator’s activities to determine the possibility of any bias in such Investigator’s research activities. If IMCS determines that there has been any such bias, IMCS shall submit a mitigation report to the applicable Funding Agency, in accordance with 42 CFR 50.605(b)(3), that shall address the impact of the bias on the Funded Research and the actions IMCS has taken to mitigate the bias and manage the FCOI. IMCS will work with the Investigator to establish an FCOI management plan, and the Investigator shall disclose the FCOI in each public presentation related to the results of the applicable Funded Research if not previously disclosed. In certain instances, the Investigator may be prohibited from continuing to work on the project or receiving any NIH funding in the future.

POLICY COORDINATOR

If you believe you have a conflict of interest or if you have any questions, please contact the Policy Coordinator, by email compliance@imcstips.com.

Version No: 1.0
Last Edited: 08/02/2021

Sidebar

"*" indicates required fields

Name*
Address*
Email me a copy
Consent

ABOUT

ABOUT IMCS

CAREERS

QUALITY POLICY

RESEARCH AT IMCS

PRODUCTS

IMCSZYME

IMCSZYME RT

IMCSTIPS

PROTEINS, ENZYMES, RESINS

GLYCO REAGENTS

TERMS

TERMS OF USE

PRIVACY POLICY

STANDARD TERMS AND CONDITIONS

FCOI POLICY

CONNECT WITH US

IMCS, Inc. Headquarters
110 Centrum Drive
Irmo, SC 29063

  • IMCS LinkedIn Page
  • IMCS Facebook Page
  • IMCS Twitter Page

COPYRIGHT © 2025 · IMCS · ALL RIGHTS RESERVED ·

Return to top

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie InfoACCEPT

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
__cf_bm30 minutesCloudflare set the cookie to support Cloudflare Bot Management.
li_gc5 months 27 daysLinkedin set this cookie for storing visitor's consent regarding using cookies for non-essential purposes.
lidc1 dayLinkedIn sets the lidc cookie to facilitate data center selection.
UserMatchHistory1 monthLinkedIn sets this cookie for LinkedIn Ads ID syncing.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
CookieDurationDescription
SRM_B1 year 24 daysUsed by Microsoft Advertising as a unique ID for visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_clck1 yearMicrosoft Clarity sets this cookie to retain the browser's Clarity User ID and settings exclusive to that website. This guarantees that actions taken during subsequent visits to the same website will be linked to the same user ID.
_clsk1 dayMicrosoft Clarity sets this cookie to store and consolidate a user's pageviews into a single session recording.
_fbp3 monthsFacebook sets this cookie to display advertisements when either on Facebook or on a digital platform powered by Facebook advertising after visiting the website.
_ga1 year 1 month 4 daysGoogle Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.
_ga_*1 year 1 month 4 daysGoogle Analytics sets this cookie to store and count page views.
_gat_gtag_UA_*1 minuteGoogle Analytics sets this cookie to store a unique user ID.
_gcl_au3 monthsGoogle Tag Manager sets the cookie to experiment advertisement efficiency of websites using their services.
_gid1 dayGoogle Analytics sets this cookie to store information on how visitors use a website while also creating an analytics report of the website's performance. Some of the collected data includes the number of visitors, their source, and the pages they visit anonymously.
_s30 minutesThis cookie is associated with Shopify's analytics suite.
_shopify_s30 minutesThis cookie is associated with Shopify's analytics suite.
_shopify_y1 year 1 month 4 daysThis cookie is associated with Shopify's analytics suite.
_y1 year 1 month 4 daysThis cookie is associated with Shopify's analytics suite.
AnalyticsSyncHistory1 monthLinkedin set this cookie to store information about the time a sync took place with the lms_analytics cookie.
CLID1 yearMicrosoft Clarity set this cookie to store information about how visitors interact with the website. The cookie helps to provide an analysis report. The data collection includes the number of visitors, where they visit the website, and the pages visited.
CONSENT2 yearsYouTube sets this cookie via embedded YouTube videos and registers anonymous statistical data.
ln_or1 dayLinkedin sets this cookie to registers statistical data on users' behaviour on the website for internal analytics.
MR7 daysThis cookie, set by Bing, is used to collect user information for analytics purposes.
SMsessionMicrosoft Clarity cookie set this cookie for synchronizing the MUID across Microsoft domains.
vuid1 year 1 month 4 daysVimeo installs this cookie to collect tracking information by setting a unique ID to embed videos on the website.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
ANONCHK10 minutesThe ANONCHK cookie, set by Bing, is used to store a user's session ID and verify ads' clicks on the Bing search engine. The cookie helps in reporting and personalization as well.
bcookie1 yearLinkedIn sets this cookie from LinkedIn share buttons and ad tags to recognize browser IDs.
bscookie1 yearLinkedIn sets this cookie to store performed actions on the website.
IDE1 year 24 daysGoogle DoubleClick IDE cookies store information about how the user uses the website to present them with relevant ads according to the user profile.
li_sugr3 monthsLinkedIn sets this cookie to collect user behaviour data to optimise the website and make advertisements on the website more relevant.
MUID1 year 24 daysBing sets this cookie to recognise unique web browsers visiting Microsoft sites. This cookie is used for advertising, site analytics, and other operations.
test_cookie15 minutesdoubleclick.net sets this cookie to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE5 months 27 daysYouTube sets this cookie to measure bandwidth, determining whether the user gets the new or old player interface.
VISITOR_PRIVACY_METADATA5 months 27 daysYouTube is a Google-owned platform for hosting and sharing videos. YouTube collects user data through videos embedded in websites, which is aggregated with profile data from other Google services in order to display targeted advertising to web visitors across a broad range of their own and other websites.
YSCsessionYoutube sets this cookie to track the views of embedded videos on Youtube pages.
yt-remote-connected-devicesneverYouTube sets this cookie to store the user's video preferences using embedded YouTube videos.
yt-remote-device-idneverYouTube sets this cookie to store the user's video preferences using embedded YouTube videos.
yt.innertube::nextIdneverYouTube sets this cookie to register a unique ID to store data on what videos from YouTube the user has seen.
yt.innertube::requestsneverYouTube sets this cookie to register a unique ID to store data on what videos from YouTube the user has seen.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
Powered by CookieYes Logo

DOWNLOAD OUR POSTERS

"*" indicates required fields

Please select the posters you would like to download*
Name*
Please provide a valid email so we can send you the download link.
Location*
Automated Liquid Handling System
Contact preferences*
Consent*
This field is for validation purposes and should be left unchanged.

Podcast Form

"*" indicates required fields

Name*
How would you like to connect?*
Please let us know what's on your mind. Have a question for us? Ask away.

Ready for a change? Get your FREE sample of IMCSzyme® RT today.

"*" indicates required fields

Name*
Location*
Consent*
This field is for validation purposes and should be left unchanged.